Loading...
•
Sep 27
Thermo Fisher Q3 2025 Earnings Report
Thermo Fisher Scientific reported its third quarter 2025 financial results, with revenue growth of 5% and adjusted EPS increasing by 10%.
Key Takeaways
Thermo Fisher Scientific delivered a strong third quarter in 2025, achieving a 5% increase in revenue to $11.12 billion and a 10% rise in adjusted diluted EPS to $5.79. The company demonstrated excellent operational performance, advanced its growth strategy with new product launches, strengthened its commercial engine, and successfully executed its capital deployment strategy through strategic acquisitions and stock repurchases.
Third quarter revenue grew 5% to $11.12 billion, compared to $10.60 billion in the prior-year quarter.
GAAP diluted EPS was $4.27, in line with the prior-year quarter, while adjusted diluted EPS increased 10% to $5.79.
The company launched innovative new products, including the Oncomine™ Dx Express Test for precision medicine and the Olink® Target 48 Neurodegeneration panel for research.
Strategic acquisitions of Solventum's Filtration and Separation business and Sanofi’s Ridgefield sterile fill-finish site, along with a collaboration with OpenAI, strengthened the company's market position and operational capabilities.
Thermo Fisher
Thermo Fisher
Thermo Fisher Revenue by Segment
Revenue by Segment
Life Sciences Solutions Revenue
CapyFin.comAnalytical Instruments Revenue
CapyFin.comSpecialty Diagnostics Revenue
CapyFin.comLaboratory Products and Biopharma Services Revenue
CapyFin.com Forward Guidance
The company will provide updated 2025 financial guidance during its earnings conference call.
Positive Outlook
- Strong operational performance reflecting the strength of their proven growth strategy.
- Successful execution of the PPI Business System.
- Continued active management of the company.
- Launch of high-impact, innovative new products.
- Strategic collaborations and acquisitions to strengthen market position.
Challenges Ahead
- No specific negative forward guidance was provided in the report.
- The company did not provide updated 2025 financial guidance in the press release, deferring it to the conference call.
- General economic conditions and related uncertainties could impact future performance.
- Dependence on customers' capital spending policies and government funding policies.
- The effect of economic and political conditions and exchange rate fluctuations on international operations.